Kenya: COVID-19 Likely to Undo HIV/Aids Gains
[Nation] Widowed and with four children, Ms Florence Atieno has been living positively with HIV for 10 years now.
[The Conversation Africa] As COVID-19 becomes the most intensely covered virus in history, there are important lessons to be drawn from the media's reporting of another global pandemic: HIV/Aids.
[WHO] Geneva -- Countries seek innovative ways to mitigate the impact of disruptions and keep services going Seventy-three countries have warned that they are at risk of stock-outs of antiretroviral (ARV) medicines as a result of the COVID-19 pandemic, according to a new WHO survey conducted ahead of the International AIDS Society's biannual conference. Twenty-four countries reported having either a critically low stock of ARVs or disruptions in the supply of these life-saving medicines.
[spotlight] Six months more of disruptions related to the COVID-19 pandemic could potentially result in a spike of an additional 500 000 AIDS-related deaths in sub-Saharan Africa by the end of next year.
[MSF] New York/Geneva -- As the Joint United Nations Programme on HIV and AIDS (UNAIDS) released its 2020 Global AIDS Update Report today, Doctors Without Borders/M édecins Sans Frontières (MSF) remains concerned that COVID-19 will interrupt lifesaving care for people living with HIV/AIDS--a group at a higher risk of becoming severely sick if infected with COVID-19.
[The Conversation Africa] The World Health Organisation (WHO) recently noted that "researchers are working at break-neck speed" to understand SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). They are also working to develop potential vaccines, medicines and other technologies that are affordable and equitable. By June 2020 - six months since it was first identified - thousands of therapeutic trials and dozens of vaccine development studies were under way, including one vaccine study each in South Africa and Nigeria
[GroundUp] Veteran activist receives award for AIDS work
[Vanguard] The Lagos State AIDS Control Agency, LSACA, has commenced the training of executives of the Nigeria Automobile Technician Association (NATA) Lagos State Chapter on HIV prevention amid COVID-19 pandemic
[Global Fund] Geneva -A new report [ download in English ] released by the Global Fund today estimates that countries affected by HIV, tuberculosis and malaria urgently need US$28.5 billion to protect the extraordinary progress achieved in the fight against the three diseases in the past two decades.
[Premium Times] The COVID-19 pandemic could affect the availability and distribution of antiretroviral drugs used in treating HIV, the Joint United Nations Programme on HIV/AIDS (UNAIDS) said on Monday.
[UCT] The Desmond Tutu HIV Foundation (DTHF) in association with the Desmond Tutu HIV Centre (DTHC), an accredited research centre at the University of Cape Town's (UCT) Institute of Infectious Disease and Molecular Medicine (IDM), has been working to accommodate and incorporate COVID-19 research and trials at its existing HIV and tuberculosis (TB) research sites.